ID

38137

Description

Study ID: 105036 Clinical Study ID: 105036 Study Title: A single-blind, randomized, placebo-controlled study to investigate the safety, tolerability, and potential effects on betamethasone pharmacokinetics of a co-administered infusion of GSK221149A in healthy female subjects Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: N/A Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 1 Study Recruitment Status: Completed Generic Name: betamethasone Trade Name: Retosiban Study Indication: Women's Health & Pregnancy - Other, pre-term labour

Mots-clés

Versions (1)
  1. 21/09/2019 21/09/2019 -
Détendeur de droits

GlaxoSmithKline

Téléchargé le

21 septembre 2019

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY-NC 3.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Betamethasone pharmacokinetics of a co-administered infusion of GSK221149A; 105036

Anglais

Investigational Product - IV Dosing

1 Formulaires  
GSK221149A IV Dose - Rapid Infusion
Description

GSK221149A IV Dose - Rapid Infusion

Alias
UMLS CUI-1
C0304229
UMLS CUI-2
C0178602
UMLS CUI-3
C0456962
Start Date and Time
Description

Experimental drug, Dosage, Rapid, Start Date, Start time

Type de données

datetime

Alias
UMLS CUI [1,1]
C0304229
UMLS CUI [1,2]
C0178602
UMLS CUI [1,3]
C0456962
UMLS CUI [1,4]
C0808070
UMLS CUI [1,5]
C1301880
Stop Date and Time
Description

Experimental drug, Dosage, Rapid, End Date, End time

Type de données

datetime

Alias
UMLS CUI [1,1]
C0304229
UMLS CUI [1,2]
C0178602
UMLS CUI [1,3]
C0456962
UMLS CUI [1,4]
C0806020
UMLS CUI [1,5]
C1522314
GSK221149A IV Dose - Continuous (post rapid) infusion
Description

GSK221149A IV Dose - Continuous (post rapid) infusion

Alias
UMLS CUI-1
C0304229
UMLS CUI-2
C0178602
UMLS CUI-3
C0549178
Start Date and Time
Description

Experimental drug, Dosage, Continuous, Start Date, Start time

Type de données

datetime

Alias
UMLS CUI [1,1]
C0304229
UMLS CUI [1,2]
C0178602
UMLS CUI [1,3]
C0549178
UMLS CUI [1,4]
C0808070
UMLS CUI [1,5]
C1301880
Stop Date and Time
Description

Experimental drug, Dosage, Continuous, End Date, End time

Type de données

datetime

Alias
UMLS CUI [1,1]
C0304229
UMLS CUI [1,2]
C0178602
UMLS CUI [1,3]
C0549178
UMLS CUI [1,4]
C0806020
UMLS CUI [1,5]
C1522314
Betamethasone 10.6 mg IV Dose
Description

Betamethasone 10.6 mg IV Dose

Alias
UMLS CUI-1
C0005308
UMLS CUI-2
C0178602
Start Date and Time
Description

Betamethasone, Dosage, Start Date, Start time

Type de données

datetime

Alias
UMLS CUI [1,1]
C0005308
UMLS CUI [1,2]
C0178602
UMLS CUI [1,3]
C0808070
UMLS CUI [1,4]
C1301880
Stop Date and Time
Description

Betamethasone, Dosage, End Date, End time

Type de données

datetime

Alias
UMLS CUI [1,1]
C0005308
UMLS CUI [1,2]
C0178602
UMLS CUI [1,3]
C0806020
UMLS CUI [1,4]
C1522314
Retour au début de la page

Similar models

Investigational Product - IV Dosing

1 Formulaires
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
GSK221149A IV Dose - Rapid Infusion
C0304229 (UMLS CUI-1)
C0178602 (UMLS CUI-2)
C0456962 (UMLS CUI-3)
Experimental drug, Dosage, Rapid, Start Date, Start time
Item
Start Date and Time
datetime
C0304229 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
C0456962 (UMLS CUI [1,3])
C0808070 (UMLS CUI [1,4])
C1301880 (UMLS CUI [1,5])
Experimental drug, Dosage, Rapid, End Date, End time
Item
Stop Date and Time
datetime
C0304229 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
C0456962 (UMLS CUI [1,3])
C0806020 (UMLS CUI [1,4])
C1522314 (UMLS CUI [1,5])
Item Group
GSK221149A IV Dose - Continuous (post rapid) infusion
C0304229 (UMLS CUI-1)
C0178602 (UMLS CUI-2)
C0549178 (UMLS CUI-3)
Experimental drug, Dosage, Continuous, Start Date, Start time
Item
Start Date and Time
datetime
C0304229 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
C0549178 (UMLS CUI [1,3])
C0808070 (UMLS CUI [1,4])
C1301880 (UMLS CUI [1,5])
Experimental drug, Dosage, Continuous, End Date, End time
Item
Stop Date and Time
datetime
C0304229 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
C0549178 (UMLS CUI [1,3])
C0806020 (UMLS CUI [1,4])
C1522314 (UMLS CUI [1,5])
Item Group
Betamethasone 10.6 mg IV Dose
C0005308 (UMLS CUI-1)
C0178602 (UMLS CUI-2)
Betamethasone, Dosage, Start Date, Start time
Item
Start Date and Time
datetime
C0005308 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
C0808070 (UMLS CUI [1,3])
C1301880 (UMLS CUI [1,4])
Betamethasone, Dosage, End Date, End time
Item
Stop Date and Time
datetime
C0005308 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
C0806020 (UMLS CUI [1,3])
C1522314 (UMLS CUI [1,4])
Retour au début de la page 

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial